Year: 2026
Type: article
Abstract: Human life expectancy has risen faster than the span of life spent in good health, producing a widening healthspan–lifespan gap that now approaches a decade globally and exceeds 12 years in the United States. Conceptual approaches for aging intervention range from largely mechanistic-based frameworks, such as the hallmarks of aging, to more function-first approaches like the World Health Organization’s intrinsic capacity model. Because biological aging is driven not by a single mechanism, but by a network of interacting hallmarks, and because many aspects of physical and cognitive function can be declining together leading up to the time period spent in the healthspan–lifespan gap, interventions that target only one process or area of function are unlikely to compress this gap substantially. This perspective makes the translational case for combining – and deliberately sequencing – potentially complementary categories of intervention: senolytics that clear senescent cells, regenerative support that supports stem cell function, joint support to enhance mobility, and nicotinamide adenine dinucleotide (NAD+) repletion that supports cellular energetics. The rationale rests on documented cross-talk among these mechanisms: as an example, senescent cells consume NAD+ and impair the niches in which stem cells operate, so clearing senescent burden plausibly creates a more permissive environment for both NAD+ restoration and regenerative signaling. A recently published preclinical study demonstrated synergistic healthspan and lifespan extension when a senolytic immunotherapy was combined with personalized mesenchymal stem cells in accelerated-aging models, providing proof of concept for the combination principle. A 12-week pilot trial using newer generation methylation clocks (e.g., DunedinPACE, OMICmAge) is planned to test an integrated nutraceutical and botanical protocol directly.
Author: Gregory Kelly
Institution: Qualia Life Sciences (United States)
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7222435169